CClinicalTrials.gg
Not yet recruitingNCT06879054LEANUpdated Mar 12, 2026

Lifestyle, Education, Activity, Nutrition (LEAN) Into Pregnancy

An interventional study of Healthy lifestyle education in Pregnancy, Preconception Education and Preconception Care, Preconception Risk, sponsored by Medical College of Wisconsin. Not yet recruiting at 1 site in United States. Open to female participants aged 18 Years to 35 Years. Per ClinicalTrials.gov, last updated 2026-03-12.

Sponsored by Medical College of Wisconsin · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Randomized
Ages
18 Years to 35 Years
Sex
Female
01

Study summary

The goal of this randomized controlled clinical trial is to determine if healthy lifestyle education can help improve cardiovascular health and reduce pregnancy complications in women during the preconception period or early pregnancy. The main aims include:

  1. Determine the feasibility and acceptability of the LEAN into pregnancy study.
  2. Determine the impact of healthy lifestyle education on Life's Essential 8 cardiovascular health score.
  3. Determine the impact of health lifestyle education on adverse pregnancy outcomes, specifically gestational diabetes and preeclampsia.

A total of 200 participants will be randomly assigned to receive healthy lifestyle education in addition to routine care, or routine care alone. Participants will be asked to participate in the following activities:

  • Blood draws to test hemoglobin A1c and lipids
  • Surveys about diet, physical activity, sleep, and tobacco use
  • Gaples Nutritional Education Modules (if applicable)
Read the detailed description

Studies investigating adverse pregnancy outcomes have shown contributing effects from increased rates of diabetes, hypertension, and abnormal cholesterol and cardiovascular disease events. Previous studies have additionally shown that lifestyle modifications such as the DASH diet, regular exercise, and reduction in stress can lower blood pressure, lower LDL cholesterol levels, and decrease poor health behaviors that are linked to cardiovascular disease. However, studies have failed to quantify the effects of lifestyle modifications on more short-term cardiovascular health that may increase adverse pregnancy outcomes. By shifting the focus from cardiovascular disease treatment to positive health promotion, it promotes a paradigm shift to focus on prevention of disease and improved societal health overall. Preliminary data from our group showed significant correlations between preeclampsia and lower availability of healthy food, which is one of the factors quantified in Life's Essential 8. A major gap in the literature remains lifestyle interventions that can lead to risk factors for cardiovascular health in pregnant populations during gestation and also in the preconception period. We believe that lifestyle interventions preconception or during pregnancy can improve cardiovascular health during gestation and reduce adverse pregnancy outcomes.

We hypothesize that the implementation of specific educational modules surrounding diet and exercise and repeated patient interaction will improve Life's Essential 8 cardiovascular score and, in those who are pregnant, potentially reduce the risk for gestational diabetes and preeclampsia.

02

Conditions studied

  • Pregnancy
  • Preconception Education
  • Preconception Care, Preconception Risk
  • Adverse Pregnancy Outcomes

Keywords

  • Preconception education
  • Cardiovascular health
  • Pregnancy
  • Lifestyle intervention
03

In context

Lead sponsor

Medical College of Wisconsin is the lead sponsor of 540 studies on the registry; 120 are open to participants now.

Of its 71 completed or terminated interventional studies of FDA-regulated products, 56 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Patients in a period of preconception who want to become pregnant within 2 years, or patients in their first trimester of pregnancy
  • English-speaking
  • At risk for preeclampsia based on the following ACOG criteria: ≥1 high-risk factor: history of preeclampsia, multifetal gestation, chronic hypertension, gestational hypertension, pregestational diabetes, renal disease, or autoimmune disease, OR ≥2 moderate-risk factors: nulliparity, obesity (BMI>30 kg/m2), family history of preeclampsia, Black or African American race, age ≥35 years, or personal history factors (previous pregnancy low birth weight, previous stillbirth, previous preterm birth, >10-year pregnancy interval).
  • At risk for gestational diabetes, defined by ACOG as a BMI > 25 plus one or more of the following risk factors: physical inactivity, first-degree relative with diabetes, high-risk race/ethnicity (African American, Latino, Native American, Asian American, Pacific Islander), previous infant weight >4,000g, previous GDM, chronic hypertension, HDL \<35, triglyceride >250, PCOS, A1c ≥ 5.7, prepregnancy BMI >40.

Exclusion criteria

Exclusion Criteria:

  • No access to a smartphone
  • Major fetal anomaly diagnosed during current pregnancy, if pregnant at consent
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
200 participants (estimated)

Study arms

  • Experimental
    LEAN Intervention

    Participants randomized to the LEAN Intervention arm will complete five modules on nutrition for optimal health and submit their completed certificates. The Gaples Institute is a free website that provides free educational modules regarding nutrition education. Each module is 10-15 minutes long and covers the power of a healthy diet, the truth about dietary fat, information about carbohydrates, facts about protein, calcium, and sodium, and simple strategies for healthy eating. Participants will also receive weekly phone calls to follow up with the progress of the implementation of the lifestyle intervention for the next three months.

    Other: Healthy lifestyle education

  • No intervention
    Standard of Care

    Participants randomized to the Standard of Care arm will receive routine prenatal or gynecologic care.

Interventions

  • OtherHealthy lifestyle education

    Healthy lifestyle education via nutritional educational modules from the Gaples Institute.

    Also known as: Health lifestyle education

06

What researchers measure

Primary outcomes

  1. Feasibility of the LEAN into Pregnancy Study

    Determine feasibility (as measured by recruitment, completion of all modules and surveys, and retention in the study for three months) of the LEAN into Pregnancy study.

    Time frame: From enrollment through the end of intervention at 3 months.

Secondary outcomes

  1. Life's Essential 8

    Determine the impact of healthy lifestyle education on Life's Essential 8 cardiovascular score pre- and post-intervention.

    Time frame: At enrollment and after intervention at 3 months.

  2. Incident rate of gestational diabetes among participants who become pregnant.

    Determine the impact of healthy lifestyle education on adverse pregnancy outcomes among participants who become pregnant, specifically the rate of gestational diabetes.

    Time frame: Up to 2 years after enrollment

  3. Acceptability of the LEAN into Pregnancy Study

    Acceptability will be measured by surveys distributed to participants in the intervention arm at the final study visit.

    Time frame: 3 months from enrollment (end of intervention)

  4. Incident rate of hypertensive disorders of pregnancy in participants who become pregnant

    Determine the impact of healthy lifestyle education on adverse pregnancy outcomes among participants who become pregnant, specifically the rate of hypertensive disorders of pregnancy.

    Time frame: Up to 2 years after enrollment

07

Study locations

1 site
  • Medical College of Wisconsin
    Milwaukee, Wisconsin 53226, United States
    • Alyssa Hernandez, DO · Contact · alyhernandez@mcw.edu · 4148055285
    • Anna Palatnik, MD · Principal investigator
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 12, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06879054
Lead sponsor
Medical College of Wisconsin
Responsible party
Anna Palatnik, MD (Associate Professor, Medical College of Wisconsin) — Principal investigator
First posted
Mar 17, 2025
Start date
Jul 1, 2026 (estimated)
Primary completion
May 2029 (estimated)
Completion
Sep 2029 (estimated)
Last update
Mar 12, 2026

Study contacts

Alyssa M Hernandez, DO
Contact
alyhernandez@mcw.edu
4148055285
Anna Palatnik, MD
principal investigator · Medical College of Wisconsin

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion